Botulax 100 IU 1 vial

Use is not recommended during lactation, as it is unknown whether botulinum toxin or its metabolites are excreted into breast milk.

Common reactions include temporary injection site pain, localized swelling, and purple bruising. Some patients may experience a mild headache or eyelid drooping if the product migrates. To ensure a quick recovery, follow our expert aftercare guide principles. Any significant swelling should be managed using proper reduction techniques.

Botulax acts by blocking the transmission of nerve impulses to the muscles, effectively preventing contraction. This relaxation allows the overlying skin to smooth out, reducing the appearance of deep folds and wrinkles. Unlike skin boosters that focus on dermal hydration, Botulax targets the muscular cause of dynamic expression. This makes it a perfect partner for the Russian lips filler technique to soften the perioral muscles.

This treatment is strictly contraindicated. No clinical safety data exists for botulinum toxin use during pregnancy or breastfeeding. We prioritize patient safety and defer all elective neurotoxin treatments until after the nursing period has concluded.

The formulation contains 100 units of purified Clostridium botulinum toxin type A, stabilized with Human Serum Albumin and Sodium Chloride.

Avoid alcohol for 24h before and after the procedure. Alcohol is a vasodilator that can increase blood flow, potentially worsening post-procedural edema and increasing the risk of visible bruising at the needle entry points.

Dosage is individualized based on muscle strength and the target area. For glabellar lines, the standard dose is typically 20 units divided into five injection sites. Practitioners should evaluate if targeted micro-dosing is appropriate for subtle smoothing in delicate zones. The 100 IU vial must be reconstituted with sterile, preservative-free 0.9% sodium chloride to the desired concentration.